Volta Finance Ltd (LON:VTA) is the topic of conversation when Hardman & Co Analyst Mark Thomas joins DirectorsTalk Interviews. Mark talks us through his recent report..
In the week that sanctions imposed on Russia began to take a knock on effect on markets around the world. Poolbeg Pharma plc (LON:POLB) announced its..
Goodbody Health Inc (AQSE:GDBY) Scientific Advisory Committee Chair Professor Clive Page caught up with DirectorsTalk for an exclusive interview to discuss how the pandemic altered people’s..
Oakley Capital Investments Limited (LON:OCI) is the topic of conversation when Hardman and Co’s Analyst Mark Thomas caught up with DirectorsTalk for an exclusive interview. Q1:..
Shield Therapeutics plc (LON:STX) is a commercial-stage pharma company delivering specialty products that address patients’ unmet medical needs, with an initial focus on iron deficiency (ID)...
Hammerson plc (LON:HMSO) has proposed a final dividend of 0.2 pence per ordinary share for the period ended 31 December 2021. The Board also intends to..
Oncimmune Holdings plc (LON:ONC), the leading global immunodiagnostics group, has today announced the signing of a commercial contract with a new top 10 global pharmaceutical company..
Accrol Group Holdings plc (LON:ACRL), the UK’s leading independent tissue convertor, has announced that Dan Wright, Executive Chairman of Accrol, has purchased 1,000,000 ordinary shares of..
Goodbody Health Inc (AQSE: GDBY) has today announced (i) its intention to initiate a normal course issuer bid (“NCIB“) through the facilities of the Canadian Securities..
